Rianita Van Onselen

Ms. Rianita Van Onselen


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2018 in Toxicon
Verified
Journal Article
Closed access
RORianita Van Onselen
Rianita Van Onselen
TDTim Downing
Tim Downing

1 August 2015 in Toxicon
Verified
Journal Article
Closed access
RORianita Van Onselen
Rianita Van Onselen
NCNiall A. Cook
Niall A. Cook
RPRichard R. Phelan
Richard R. Phelan
TDTim G. Downing
Tim G. Downing

3 May 2017 in Neurotoxicity Research
Verified
Journal Article
Closed access
PDF file
RORianita Van Onselen
Rianita Van Onselen
LVL. Venables
L. Venables
MVMaryna van de Venter
Maryna van de Venter
TDT. G. Downing
T. G. Downing

14 December 2017 in Toxins
Verified
Journal Article
Open access
PDF file
RORianita Van Onselen
Rianita Van Onselen
SDSimoné Downing
Simoné Downing
GKGabré Kemp
Gabré Kemp
TDTim Downing
Tim Downing
Misincorporation of β-N-methylamino-l-alanine (BMAA) into proteins has been proposed to be a mechanism of toxicity to explain the role of BMAA in neurodegenerative disease development. However, studies have shown that all detectable BMAA can be removed from proteins by SDS-PAGE purification and that the toxicity of l-canavanine cannot be reproduced in prokaryotes or in a rat pheochromocytoma cell line, strongly indicating that the misincorporation hypothesis of BMAA should be re-investigated. The aim of this study was therefore to determine if BMAA misincorporates into proteins in cells of human origin with subsequent misincorporation-type toxicity. Almost complete loss of viability in response to exposure to l-4-fluorophenylalanine and l-m-tyrosine was observed in all of the cell lines, corresponding to a concentration-dependent increase of the analogues in protein extracts from exposed cells. In contrast, BMAA exposure resulted in slight toxicity in one of the cell lines but the observed toxicity was not the result of misincorporation of BMAA into proteins, as no BMAA was detected in any of the SDS-PAGE purified protein extracts that were obtained from the cells following BMAA exposure. The results show that BMAA is not misincorporated into human proteins and that misincorporation is not a valid mechanism of toxicity.


20 January 2019 in International Journal of Toxicology
Verified
Journal Article
Open access
PDF file
RORianita Van Onselen
Rianita Van Onselen
TDTim G. Downing
Tim G. Downing
The naturally produced, nonprotein amino acid β-N-methylamino-l-alanine (BMAA) has been proposed as a significant contributor to sporadic neurodegenerative disease development worldwide. However, the existing hypothesized mechanisms of toxicity do not adequately explain the role of BMAA in neurodegenerative disease development. There is evidence for BMAA-induced enzyme inhibition, but the effect of BMAA on human stress response enzymes has received little attention, despite the well-described role of oxidative stress in neurodegenerative disease development. The aim of this study was therefore to investigate the effect of BMAA on human catalase activity and compare it to the known inhibitor 3-amino-1,2,4-triazole. BMAA inhibited human erythrocyte catalase in a cell-free exposure to the same extent as the known inhibitor. Based on enzyme kinetics, the inhibition appears to be noncompetitive, possibly as a result of BMAA binding in the nicotinamide adenine dinucleotide phosphate (NADPH) binding site. BMAA-induced catalase inhibition was also observed in a human cell line culture. We therefore propose that BMAA-induced enzyme inhibition, specifically catalase inhibition, is a mechanism of toxicity that may contribute to the neurotoxicity of BMAA, further supporting the role of BMAA in neurodegenerative disease development.